Literature DB >> 11226580

Determination of the mutation rate of poliovirus RNA-dependent RNA polymerase.

V R Wells1, S J Plotch, J J DeStefano.   

Abstract

The fidelity of poliovirus RNA-dependent RNA polymerase (3D(pol)) was determined using a system based on the fidelity of synthesis of the alpha-lac gene which codes for a subunit of beta-galactosidase. Synthesis products are screened for mutations by an alpha-complementation assay, in which the protein product from alpha-lac is used in trans to complement beta-galactosidase activity in bacteria that do not express alpha-Lac. Several polymerases have been analyzed by this approach allowing comparisons to be drawn. The assay included RNA synthesis by 3D(pol) on an RNA template that coded for the N-terminal region of alpha-Lac. The product of this reaction was used as a template for a second round of 3D(pol) synthesis and the resulting RNA was reverse transcribed to DNA by MMLV-RT. The DNA was amplified by PCR and inserted into a vector used to transform Escherichia coli. The bacteria were screened for beta-galactosidase activity by blue-white phenotype analysis with white or faint blue colonies scored as errors made during synthesis on alpha-lac. Results showed a mutation rate for 3D(pol) corresponding to approximately 4.5x10(-4) errors per base (one error in approximately 2200 bases). Analysis of mutations showed that base substitutions occurred with greater frequency than deletions and insertions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11226580     DOI: 10.1016/s0168-1702(00)00256-2

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  12 in total

1.  Primer-dependent synthesis by poliovirus RNA-dependent RNA polymerase (3D(pol)).

Authors:  V Rodriguez-Wells; S J Plotch; J J DeStefano
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

2.  Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range.

Authors:  Jaume Jorba; Ray Campagnoli; Lina De; Olen Kew
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

3.  The relationship between mutation frequency and replication strategy in positive-sense single-stranded RNA viruses.

Authors:  Gaël Thébaud; Joël Chadoeuf; Marco J Morelli; John W McCauley; Daniel T Haydon
Journal:  Proc Biol Sci       Date:  2009-11-11       Impact factor: 5.349

4.  Insertion-and-Deletion Mutations between the Genomes of SARS-CoV, SARS-CoV-2, and Bat Coronavirus RaTG13.

Authors:  Tetsuya Akaishi
Journal:  Microbiol Spectr       Date:  2022-06-06

Review 5.  Poliomyelitis is a current challenge: long-term sequelae and circulating vaccine-derived poliovirus.

Authors:  Jorge Quarleri
Journal:  Geroscience       Date:  2022-10-19       Impact factor: 7.581

6.  Effect of reaction conditions and 3AB on the mutation rate of poliovirus RNA-dependent RNA polymerase in a alpha-complementation assay.

Authors:  Jeffrey J DeStefano
Journal:  Virus Res       Date:  2009-10-20       Impact factor: 3.303

7.  Human immunodeficiency virus reverse transcriptase displays dramatically higher fidelity under physiological magnesium conditions in vitro.

Authors:  Vasudevan Achuthan; Brian J Keith; Bernard A Connolly; Jeffrey J DeStefano
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

Review 8.  Dissecting nucleotide selectivity in viral RNA polymerases.

Authors:  Chunhong Long; Moises Ernesto Romero; Daniel La Rocco; Jin Yu
Journal:  Comput Struct Biotechnol J       Date:  2021-06-04       Impact factor: 7.271

9.  Alternative divalent cations (Zn²⁺, Co²⁺, and Mn²⁺) are not mutagenic at conditions optimal for HIV-1 reverse transcriptase activity.

Authors:  Vasudevan Achuthan; Jeffrey J DeStefano
Journal:  BMC Biochem       Date:  2015-05-03       Impact factor: 4.059

10.  Examination of soluble integrin resistant mutants of foot-and-mouth disease virus.

Authors:  Paul Lawrence; Michael LaRocco; Barry Baxt; Elizabeth Rieder
Journal:  Virol J       Date:  2013-01-02       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.